Search Results - "Cantet, C."

Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study) by Giudici, K.V., de Souto Barreto, P., Beard, J., Cantet, C., Araujo de Carvalho, I., Rolland, Y., Vellas, B.

“…•Intrinsic capacity (IC) is the composite of all the physical and mental capacities of an individual.•The intrinsic capacity Z-score included four domains:…”
Get full text

Cognitive changes with omega-3 polyunsaturated fatty acids in non-demented older adults with low omega-3 index by Hooper, Claudie, de Souto Barreto, P., Coley, N., Cantet, C., Cesari, M., Andrieu, S., Vellas, B.

“…Objectives To investigate the changes in specific domains of cognitive function in older adults reporting subjective memory complaints with a low omega-3 index…”
Get full text

Causal inference for the covariance between breeding values under identity disequilibrium by Cantet, Rodolfo J C, Angarita-Barajas, Belcy K, Forneris, Natalia S, Munilla, Sebastián

“…The covariance matrix of breeding values is at the heart of prediction methods. Prediction of breeding values can be formulated using either an "observed" or a…”
Get full text

Vitamin D, homocysteine and n−3PUFA status according to physical and cognitive functions in older adults with subjective memory complaint: Results from cross-sectional study of the MAPT trial by Chhetri, J.K., de Souto Barreto, P., Soriano, G., Gennero, I., Cantet, C., Vellas, B.

“…The aim of this study was to investigate the nutritional markers (Vitamin D, homocysteine, n−3PUFA) status of older subjects aged 70 years and older with…”
Get full text

Omega-3 Supplementation for the Prevention of Cognitive Decline in Older Adults: Does It Depend on Homocysteine Levels? by Maltais, Mathieu, de Souto Barreto, P., Bowman, G. L., Smith, A. D., Cantet, C., Andrieu, S., Rolland, Y.

“…Background Recent evidence point towards an interaction between omega-3 (n-3) polyunsaturated fatty acids (PUFA) and plasma homocysteine (Hcy). Objectives This…”
Get full text

Legacies of domestication, trade and herder mobility shape extant male zebu cattle diversity in South Asia and Africa by Pérez-Pardal, Lucía, Sánchez-Gracia, Alejandro, Álvarez, Isabel, Traoré, Amadou, Ferraz, J. Bento S., Fernández, Iván, Costa, Vânia, Chen, Shanyuan, Tapio, Miika, Cantet, Rodolfo J. C., Patel, Ajita, Meadow, Richard H., Marshall, Fiona B., Beja-Pereira, Albano, Goyache, Félix

“…All tropically adapted humped cattle ( Bos indicus or “zebu”), descend from a domestication process that took place >8,000 years ago in South Asia. Here we…”
Get full text

Effect of Multidomain Intervention, Omega-3 Polyunsaturated Fatty Acids Supplementation or their Combinaison on Cognitive Function in Non-Demented Older Adults According to Frail Status: Results from the MAPT Study by Tabue-Teguo, Maturin, Barreto de Souza, P., Cantet, C., Andrieu, S., Simo, N., Fougère, B., Dartigues, J. F., Vellas, B.

“…Background: Aim The aim of this study was to explore whether multidomain intervention (MI) and Omega-3 Polyunsaturated Fatty Acids supplementation can modify…”
Get full text

The effect of the H -1 scaling factors τ and ω on the structure of H in the single-step procedure by Martini, Johannes W R, Schrauf, Matias F, Garcia-Baccino, Carolina A, Pimentel, Eduardo C G, Munilla, Sebastian, Rogberg-Muñoz, Andres, Cantet, Rodolfo J C, Reimer, Christian, Gao, Ning, Wimmer, Valentin, Simianer, Henner

“…The single-step covariance matrix H combines the pedigree-based relationship matrix [Formula: see text] with the more accurate information on realized…”
Get full text

Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings by Payoux, P., Delrieu, J., Gallini, A., Adel, D., Salabert, A. S., Hitzel, A., Cantet, C., Tafani, M., De Verbizier, D., Darcourt, J., Fernandez, Ph, Monteil, J., Carrié, I., Voisin, T., Gillette-Guyonnet, S., Pontecorvo, M., Vellas, B., Andrieu, S.

“…Purpose Despite good to excellent inter-reader agreement in the evaluation of amyloid load on PET scans in subjects with Alzheimer's disease, some equivocal…”
Get full text

Is the 25-hydroxy-vitamin D serum concentration a good marker of frailty? by Krams, Thomas, Cesari, M., Guyonnet, S., Abellan van Kan, G., Cantet, C., Vellas, B., Rolland, Y.

“…Introduction The phenotype proposed by Fried and colleagues is a widely used operational definition of frailty defining such state of extreme vulnerability of…”
Get full text

Predictive factors of hospitalizations in Alzheimer’s disease: A two-year prospective study in 686 patients of the REAL.FR study by Voisin, T., Andrieu, S., Cantet, C., Vellas, B.

“…Background During the course of the Alzheimer’s disease (AD), many patients need to be hospitalized either due to the direct consequences of the disease…”
Get full text

Red Blood Cell Omega-3 Fatty Acid Composition and Psychotropic Drug Use in Older Adults: Results from the MAPT Study by Gallini, Adeline, Yrondi, A., Cantet, C., Poncet, M., Vellas, B., Schmitt, L., Andrieu, S.

“…Low docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) concentration has been associated with the development of some psychiatric disorders. Objectives…”
Get full text

Effect of a 1-Year Nutritional Blend Supplementation on Plasma p-tau181 and GFAP Levels among Community-Dwelling Older Adults: A Secondary Analysis of the Nolan Trial by Giudici, K V, de Souto Barreto, P, Guyonnet, S, Cantet, C, Zetterberg, H, Boschat, C, Hudry, J, Andrieu, S, Schmitt, J A J, Vellas, B, Blennow, K

“…Observational studies and some randomized controlled trials have suggested that nutritional supplementation could be a possible intervention pathway to prevent…”
Get full text

Incidence and predictive factors of depressive symptoms in Alzheimer’s disease: The REAL.FR study by Arbus, Christophe, Gardette, V., Cantet, C. E., Andrieu, S., Nourhashemi, F., Schmitt, L., Vellas, B.

“…Background Many patients develop psychiatric and behavioral disturbances in the course of Alzheimer’s disease (AD). Among these disturbances, depressive…”
Get full text

Differences in resource use and costs of dementia care between European countries: Baseline data from the ictus study by Gustavsson, Anders, Jonsson, L., Rapp, T., Reynish, E., Ousset, P. J., Andrieu, S., Cantet, C., Winblad, B., Vellas, B., Wimo, A.

“…Objectives This study aimed to estimate the costs of formal and informal care of patients with Alzheimer's disease, to compare care costs across European…”
Get full text

PREDICTIVE FACTORS OF HOSPITALIZATIONS IN ALZHEIMER'S DISEASE: A TWO-YEAR PROSPECTIVE STUDY IN 686 PATIENTS OF THE REAL.FR STUDY by VOISIN, T, ANDRIEU, S, CANTET, C, VELLAS, B, GROUP, ReaL. fr

“…During the course of the Alzheimer's disease (AD), many patients need to be hospitalized either due to the direct consequences of the disease itself, or due to…”
Get full text

How should we deal with missing data in clinical trials involving Alzheimer's disease patients? by Coley, N, Gardette, V, Cantet, C, Gillette-Guyonnet, S, Nourhashemi, F, Vellas, B, Andrieu, S

“…Missing data are frequent in Alzheimer's disease (AD) trials due to the age of participants and the nature of the disease. This can lead to bias and decreased…”
Get more information

The Cost-Effectiveness of Three Prevention Strategies in Alzheimer’s Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT) by Costa, Nadège, Mounié, M., Pagès, A., Derumeaux, H., Rapp, T., Guyonnet, S., Coley, N., Cantet, C., Carrié, I., Andrieu, S., Molinier, L.

“…Background To date, no curative treatment is available for Alzheimer’s disease (AD). Therefore, efforts should focus on prevention strategies to improve the…”
Get full text

Longitudinal Course of Agitation and Aggression in Patients with Alzheimer’s Disease in a Cohort study: Methods, Baseline and Longitudinal Results of the A3C Study by De Mauleon, Adelaide, Delrieu, J., Cantet, C., Vellas, B., Andrieu, S., Rosenberg, P. B., Lyketsos, C. G., Martin, M. Soto, Bories, L., Roustan, A., Gasnier, Y., Bordes, S., Cufi, M. N., Desclaux, F., Felicelli, V., Gaits, N., Uguen, T., Teste, P., Pere-Saun, M., Pucheu, J. F., Salles, J. P.

“…Background To present methodology, baseline results and longitudinal course of the Agitation and Aggression in patients with Alzheimer’s Disease Cohort (A3C)…”
Get full text

Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials by Chhetri, J. K., de Souto Barreto, P., Cantet, C., Cesari, M., Coley, N., Andrieu, S., Vellas, Bruno

“…Defining the primary cognitive endpoint is a major decision for Alzheimer’s disease preventive trials. As an example for further trials we present in detail…”
Get full text